Besorio, John Michael Dave S.
HRN: 24-18-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/02/2023
OXACILLIN 500MG (VIAL)
12/02/2023
12/09/2023
IV
500mg
Q6H
Bacterial Skin Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes